You're in the right place! Welcome to our newly updated ESC website.
Start exploring or use our powerful new search engine to find what you need. 

Update on heart failure and diabetes: what is the potential role of semaglutide and the combination of GIP-GLP1 receptor agonists in the management of HF?- Video

7 Jan, 2025
Scientific

Photo
Professor Nikolaus Marx

RWTH University Hospital Aachen, Aachen, Germany

Photo
Doctor Ruxandra Maria Christodorescu

University of Medicine and Pharmacy Victor Babes, Timişoara, Romania

In this video, Professor Marx (RWTH University Hospital Aachen, Aachen, Germany) joins Associate Professor Christodorescu (University of Medicine and Pharmacy Victor Babes, Timişoara, Romania) to discuss updates on heart failure and diabetes: what is the potential role of semaglutide and the combination of GIP-GLP1 receptor agonists in the management of HF?

Note to editors

The content of this article reflects the personal opinion of the author/s and is not necessarily the official position of the European Society of Cardiology.